LABP

Landos Biopharma, Inc. Common Stock

Delisted

LABP was delisted on the 23rd of May, 2024.

0 hedge funds and large institutions have $0 invested in Landos Biopharma, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1 -$31.9M
2 -$1.07M
3 -$406K
4
Macquarie Group
Macquarie Group
Australia
-$316K
5
VF
Virtu Financial
New York
-$313K